An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer
Ontology highlight
ABSTRACT: This observational study evaluates the efficacy and safety of capecitabine in combination with oxaliplatin in the adjuvant setting in participants with Stage III colon cancer. Data were collected from each participant for up to 36 months or until disease recurrence.
DISEASE(S): Colorectal Cancer,Colorectal Neoplasms
PROVIDER: 2113422 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA